Testing a new imaging agent for large vessel vasculitis
Treatments studied
Part of Brain & nervous system, Heart & circulation, Immune system & allergy, Skin clinical trials.
This study tests a special radioactive tracer, 18F-AzaFol, to see if it can help diagnose large vessel vasculitis, a type of inflammation in the arteries. The results will be compared with standard FDG PET/CT scans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years or older and your doctor suspects you have giant cell arteritis (GCA), a kind of vasculitis.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
- You do not have a folate (folic acid) deficiency.
- You can avoid eating or drinking anything except water for 6 hours before the PET scan.
- You can lie still for about 45 minutes for the scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether different MRI scanning details can better help doctors diagnose giant cell arteritis. If you’re being sent for an injected MRI because GCA is suspected, your scan results may help improve how future diagnoses are made.
This study is looking for biomarkers (biological clues) in people with newly diagnosed or flaring giant cell arteritis (GCA) or polymyalgia rheumatica (PMR). Participating may help researchers find better ways to diagnose and monitor these conditions.
This trial tests how well a special MRI (picture scan) can evaluate giant cell arteritis when it’s newly suspected and symptoms started recently. It may help doctors confirm the diagnosis and decide on treatment sooner by comparing MRI findings with standard testing like biopsy or ultrasound.
This study tests a new type of PET/CT scanner that takes images of a larger area of the body to better see inflammation in the blood vessels in people with large vessel vasculitis (LVV). It aims to improve how doctors detect and monitor this condition.
This trial is testing a new imaging method (68Ga-FAPI PET/CMR) to better see and understand heart problems. It might help doctors diagnose or monitor conditions like heart failure or inflammation.
This trial uses a special PET scan tracer to see if it can help find and monitor diseases linked to a protein called FAP. It is for both cancer patients needing a biopsy and healthy volunteers.
Hear when a new Giant Cell Arteritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.